Publications by authors named "Haley N Johnson"
Chronic kidney disease (CKD) affects approximately 14% of adults in the United States and is present in at least 10% of the population worldwide. Blood glucose and blood pressure control are imperative to adequately manage CKD as they are the only primary prevention measures for the condition. Recent changes in CKD evaluation and medication therapies that modify disease progression and aid in managing complications such as anemia of CKD have emerged, including a newly approved mineralocorticoid receptor antagonist and hypoxia-inducible factor-prolyl hydroxylase inhibitor, respectively.
View Article and Find Full Text PDFArticle Synopsis
- The objective of the study was to assess the safety and effectiveness of daprodustat, a treatment for anemia in patients with chronic kidney disease (CKD).
- Literature was analyzed to determine the drug's effects on hemoglobin levels and the occurrence of major adverse cardiovascular events compared to traditional treatments.
- Daprodustat was found to be effective in raising hemoglobin levels in CKD patients on dialysis without increasing cardiovascular risks, and it's been approved for use by the FDA in those patients since 2023.
Evaluation of an individual examination remediation policy in a professional pharmacy course.
Curr Pharm Teach Learn
November 2023
Introduction: Maintaining institutional remediation policies is required for pharmacy education accreditation, but specific policies and students' perceptions of remediation are not well described in the literature. The purpose of this research was to determine whether the individual examination remediation policy utilized in a biomedical literature evaluation course was a viable approach to ensuring positive student experiences and success.
Methods: This study utilized a pre-/post-quantitative survey design.